Skip to main content
Cachet Pharmaceutical Co., Ltd. logo

Cachet Pharmaceutical Co., Ltd. — Investor Relations & Filings

Ticker · 002462 ISIN · CNE100000SN0 LEI · 300300CBONJS7HUOCX64 Shenzhen Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 1,441 across all filing types
Latest filing 2018-07-10 Report Publication Anno…
Country CN China
Listing Shenzhen Stock Exchange 002462

About Cachet Pharmaceutical Co., Ltd.

https://www.cachet.com.cn

Cachet Pharmaceutical Co., Ltd. specializes in the distribution and retail of pharmaceutical products and medical devices. The company operates an extensive wholesale network and a chain of retail pharmacies, providing comprehensive supply chain solutions to healthcare institutions and end-consumers. Its core operations include the procurement, storage, and logistics of western medicines, traditional Chinese medicines, and high-value medical consumables. Cachet Pharmaceutical emphasizes modern logistics management and professional pharmaceutical services, leveraging a robust distribution infrastructure to ensure the efficient delivery of healthcare products. The company also focuses on hospital supply chain integration and community-based retail services to enhance healthcare accessibility.

Recent filings

Filing Released Lang Actions
第五届董事会第二十五次会议决议的公告
Report Publication Announcement Classification · 95% confidence The document is an announcement of the board of directors meeting resolution approving the 2018 semi-annual report. It includes summary financial data for the first half of 2018 but does not contain the full report itself. The document states that the full semi-annual report is available on the company's designated information disclosure website and media, indicating this is an announcement rather than the report itself. The document length is short (734 characters), consistent with an announcement rather than a full interim report. Therefore, this is a Report Publication Announcement (RPA) rather than the actual Interim/Quarterly Report (IR).
2018-07-10 Chinese
2018年半年度报告摘要
Interim / Quarterly Report Classification · 95% confidence The document is titled '嘉事堂药业股份有限公司 2018 年半年度报告摘要', which translates to 'Cachet Pharmaceutical Co., Ltd. 2018 Semi-Annual Report Summary'. It contains detailed financial data for the first half of 2018, including revenue, net profit, cash flow, earnings per share, and asset information. It also includes management discussion and analysis of business operations, financial conditions, and risk management. The document is approximately 4660 characters long, which is relatively short but contains substantive financial data and analysis, not just an announcement or a link to a report. The content matches the characteristics of an Interim / Quarterly Report (IR), as it covers a period shorter than a full fiscal year and includes actual financial statements and detailed discussion. Therefore, the correct classification is IR (Interim / Quarterly Report). H1 2018
2018-07-10 Chinese
2018年半年度报告
Interim / Quarterly Report Classification · 95% confidence The document is titled "嘉事堂药业股份有限公司 2018 年半年度报告全文" which translates to "Cachet Pharmaceutical Co., Ltd. 2018 Semi-Annual Report Full Text." It explicitly states the report period as January 1, 2018 to June 30, 2018, indicating it covers a half-year period. The content includes detailed financial data such as revenue, net profit, cash flow analysis, business overview, risk factors, and management discussion and analysis. The length is substantial (15,000 characters), and it contains actual financial statements and substantive financial data. This matches the definition of an Interim / Quarterly Report (IR), which is a comprehensive financial report for a period shorter than a full fiscal year. It is not an announcement or a certification, but the full report itself. Therefore, the correct classification is IR with high confidence. H1 2018
2018-07-10 Chinese
独立董事关于第五届董事会第二十五次会议相关事项的专项说明及独立意见
Board/Management Information Classification · 95% confidence The document is a special statement and independent opinion from the independent directors of 嘉事堂药业股份有限公司 regarding matters discussed at the 25th meeting of the 5th board of directors. It references compliance with regulatory guidelines on related party transactions and external guarantees, and confirms no misuse of company funds or illegal guarantees during the reporting period. The document is a formal board/management related disclosure focusing on governance and compliance matters, not a full audit report or annual report. It is not a report publication announcement or certification letter but a detailed board-related statement. Therefore, it fits best under Board/Management Information (MANG). The document length is short but contains substantive content related to board opinions and governance.
2018-07-10 Chinese
2018年半年度财务报告
Interim / Quarterly Report Classification · 100% confidence The document is titled '嘉事堂药业股份有限公司 2018 年半年度财务报告' which translates to 'Jia Shi Tang Pharmaceutical Co., Ltd. 2018 Semi-Annual Financial Report'. It includes detailed financial statements such as consolidated balance sheets, profit statements, cash flow statements, and notes on accounting policies and estimates. The presence of comprehensive financial data for a half-year period and the term '半年度财务报告' (semi-annual financial report) clearly indicates this is an Interim / Quarterly Report. The document length is substantial (15,000 characters), and it contains actual financial statements and analysis, not just an announcement or certification. Therefore, the correct classification is Interim / Quarterly Report (IR). H1 2018
2018-07-10 Chinese
关于控股股东进行股票补充质押的公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement regarding the supplementary pledge of shares by the company's controlling shareholder. It details the number of shares pledged, pledge dates, pledgee, and the risk assessment related to the pledge. There is no financial report, earnings data, or management discussion. The document is an update on financing activity related to share pledges, which fits the category of Capital/Financing Update (CAP). The document length is short and it is not an announcement of a report publication or a certification. Therefore, the classification is CAP with high confidence.
2018-07-02 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.